Treatment recommendations were part and parcel ... It's really an ongoing process and we've been fortunate to have GRAPPA get support from a lot of pharma. Of course, there has been a big interest ...

Both GRAPPA and ASAS plan to use the term "difficult-to-treat" or "treatment refractory" to describe true biologically refractory inflammatory disease and are categorizing the larger, heterogenous ...

A new publication by the GRAPPA–OMERACT group provides recommendations and a useful framework for physicians on the use of composite measures and treatment targets in psoriatic arthritis.